Short NJ, Macaron W, Konopleva M, Ravandi F, et al. Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab. Am J Hematol 2022 Mar 10. doi: 10.1002/ajh.26526.
PMID: 35266566